Clinical Trial Update: To Evaluate the Efficacy and Safety of LuminoMark Injection in Patients With Nonpalpable Breast Lesions(Phase 3) [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating LuminoMark injection for efficacy and safety in patients with nonpalpable breast lesions has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Diseases

Drugs mentioned

• LUminoMark

Snippet

Sponsor: Hanlim Pharm. Co., Ltd. | Conditions: Breast Diseases | Phase 3 | Status: COMPLETED